keyword
MENU ▼
Read by QxMD icon Read
search

hormonal treatment

keyword
https://read.qxmd.com/read/30772872/-clinical-assessment-of-fourteen-cases-of-thoracic-endometriosis
#1
Naoya Ishibashi, Toshiharu Tabata, Akira Koyanagi, Ryo Nonomura, Takanobu Sasaki, Hideki Mitomo, Takafumi Sugawara, Takashi Kondo, Kazuhiro Murakami, Motoyasu Sagawa
We retrospectively assessed the clinical and pathological features of 14 patients with thoracic endometriosis who were treated at our hospital from 2007 to 2017. Thirteen patients presented pneumothorax and 1 patient presented bloody sputum. All were treated surgically. Pneumothorax occurs on the right side in all 13 cases and bloody sputum was from left side lesion. Ten patients presented symptoms closely related with their menstrual cycle (days -2 to 5). At surgery, dark red or dark brown spots, small hiatus and scar-like findings on the surface of the visceral pleura or diaphragm were identified in all cases...
February 2019: Kyobu Geka. the Japanese Journal of Thoracic Surgery
https://read.qxmd.com/read/30772671/initial-results-of-a-randomized-phase-iii-trial-of-high-dose-image-guided-radiation-with-or-without-androgen-deprivation-therapy-for-intermediate-risk-prostate-cancer
#2
Carlos E Vargas, Now Bahar Alam, Mitchell Terk, Joshua R Niska, Jamie Cesareti, Douglas Swartz, Apoorva Vashi, Ali Kasraeian, C Shawn West, Marc Blasser, Chris Moore
BACKGROUND: Prior randomized studies have shown a survival benefit using combined androgen deprivation therapy (ADT) and radiation therapy for intermediate-risk prostate cancer. However, these studies either used low doses of radiation (66.6 Gy to isocenter) or imaged guidance was not available. This study reports the initial differences for high dose image guided radiation with or without ADT. METHODS: From 2012 to 2014, 56 patients were treated with and 60 patients without 6 months of ADT (N = 116) in our phase III randomized trial for intermediate-risk prostate cancer...
February 10, 2019: Cancer Treatment and Research Communications
https://read.qxmd.com/read/30772500/stem-leydig-cell-regeneration-in-the-adult-rat-testis-is-inhibited-after-a-short-term-triphenyltin-exposure
#3
Chaobo Ni, Yinghui Fang, Xiuxiu Chen, Keyang Wu, Huitao Li, Yiyan Wang, Lin Zhenkun, Qingquan Lian, Ren-Shan Ge
Triphenyltin (TPT) is an organotin compound and may be an endocrine disruptor, impairing the male reproductive system. However, the effect of short-term TPT exposure on stem Leydig cell regeneration later on remains unknown. Here, we show that TPT affects stem Leydig cell regeneration in the adult rat testis. Adult male Sprague Dawley rats were gavaged with TPT (0, 0.5, 1.0, 2.0 mg/kg body weight/day) for 10 days, followed by a single intraperitoneal injection of ethane dimethane sulfonate (EDS, 75 mg/kg body weight) to eliminate Leydig cells...
February 14, 2019: Toxicology Letters
https://read.qxmd.com/read/30772372/auxological-characteristics-of-pediatric-patients-with-permanent-or-transient-isolated-growth-hormone-deficiency-response-to-treatment-and-final-height
#4
Beatriz Villafuerte, Raquel Barrio, María Martín-Frías, Milagros Alonso, Belén Roldán
INTRODUCTION: Treatment with recombinant human growth hormone (rhGH) has been shown to improve adult height in pediatric patients with GH deficiency (GHD). However, reassessment of patients after they reach their final height shows some of them have permanent GH deficiency (PGHD), while others had a transient deficiency (TGHD). The study objective was to assess, in a cohort of pediatric patients with GHD, potential differences in response to treatment with rhGH depending on whether deficiency is permanent or transient...
February 13, 2019: Endocrinología, Diabetes y Nutrición
https://read.qxmd.com/read/30772358/biological-evolution-of-castration-resistant-prostate-cancer
#5
REVIEW
Alastair Davies, Vincenza Conteduca, Amina Zoubeidi, Himisha Beltran
CONTEXT: Recent studies focused on the molecular characterization of metastatic prostate cancer have identified genomic subsets and emerging resistance patterns. Detection of these alterations in patients has potential implications for therapy selection and prognostication. OBJECTIVE: The primary objective is to review the current landscape of clinical and molecular biomarkers in advanced prostate cancer and understand how they may reflect underlying tumor biology...
February 13, 2019: European Urology Focus
https://read.qxmd.com/read/30771872/the-clinical-use-of-circulating-tumor-cells-ctcs-enumeration-for-staging-of-metastatic-breast-cancer-mbc-international-expert-consensus-paper
#6
REVIEW
Massimo Cristofanilli, Jean-Yves Pierga, James Reuben, Alfred Rademaker, Andrew A Davis, Dieter J Peeters, Tanja Fehm, Franco Nolé, Rafael Gisbert-Criado, Dimitrios Mavroudis, Salvatore Grisanti, Mario Giuliano, Jose A Garcia-Saenz, Justin Stebbing, Carlos Caldas, Paola Gazzaniga, Luis Manso, Rita Zamarchi, Angela Fernandez de Lascoiti, Leticia De Mattos-Arruda, Michail Ignatiadis, Luc Cabel, Steven J van Laere, Franziska Meier-Stiegen, Maria-Teresa Sandri, Jose Vidal-Martinez, Eleni Politaki, Francesca Consoli, Daniele Generali, Maria Rosa Cappelletti, Eduardo Diaz-Rubio, Jonathan Krell, Sarah-Jane Dawson, Cristina Raimondi, Annemie Rutten, Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich-Franz Solomayer, Laura Zorzino, Lauren Darrigues, Jorge S Reis-Filho, Lorenzo Gerratana, Stefan Michiels, François-Clément Bidard, Klaus Pantel
BACKGROUND: The heterogeneity of metastatic breast cancer (MBC) necessitates novel biomarkers allowing stratification of patients for treatment selection and drug development. We propose to use the prognostic utility of circulating tumor cells (CTCs) for stratification of patients with stage IV disease. METHODS: In a retrospective, pooled analysis of individual patient data from 18 cohorts, including 2436 MBC patients, a CTC threshold of 5 cells per 7.5 ml was used for stratification based on molecular subtypes, disease location, and prior treatments...
February 2019: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/30771790/effects-of-n-acetyl-cysteine-supplementation-on-sperm-quality-chromatin-integrity-and-level-of-oxidative-stress-in-infertile-men
#7
Rahil Jannatifar, Kazem Parivar, Nasim Hayati Roodbari, Mohammad Hossein Nasr-Esfahani
BACKGROUND: Infertile men have higher levels of semen reactive oxygen species (ROS) than fertile men. High levels of semen ROS can cause sperm dysfunction, sperm DNA damage and reduced male reproductive potential. This study investigated the effects of supplementation with N-acetyl-cysteine (NAC) on the sperm quality, chromatin integrity and levels of oxidative stress in infertile men. METHODS: The study was carried out in the unit of ACECR Infertility Research Center, Qom, Iran...
February 16, 2019: Reproductive Biology and Endocrinology: RB&E
https://read.qxmd.com/read/30771711/brain-region-specific-glucagon-like-peptide-1-receptors-regulate-alcohol-induced-behaviors-in-rodents
#8
Daniel Vallöf, Aimilia Lydia Kalafateli, Elisabet Jerlhag
Glucagon-like peptide 1 (GLP-1), an incretin hormone that reduces food intake, was recently established as a novel regulator of alcohol-mediated behaviors. Clinically available analogues pass freely into the brain, but the mechanisms underlying GLP-1-modulated alcohol reward remains largely unclear. GLP-1 receptors (GLP-1R) are expressed throughout the nuclei of importance for acute and chronic effects of alcohol, such as the laterodorsal tegmental area (LDTg), the ventral tegmental area (VTA) and the nucleus accumbens (NAc)...
February 8, 2019: Psychoneuroendocrinology
https://read.qxmd.com/read/30771372/corticosterone-mediated-functional-and-structural-plasticity-in-corticotropin-releasing-hormone-neurons
#9
REVIEW
Thibault P Bittar, Betina B Nair, Joon S Kim, Dhananjie Chandrasekera, Aidan Sherrington, Karl J Iremonger
Corticosteroid stress hormones drive a multitude of adaptations in the brain. Hypothalamic corticotropin-releasing hormone (CRH) neurons control the circulating levels of corticosteroid stress hormones in the body and are themselves highly sensitive to corticosteroids. CRH neurons have been shown to undergo various adaptions in response to acute stress hormone elevations. However, their structural and physiological changes under chronically elevated corticosterone are less clear. To address this, we determined the structural and functional changes in CRH neurons in the paraventricular nucleus of the hypothalamus following 14 days of corticosterone treatment...
February 13, 2019: Neuropharmacology
https://read.qxmd.com/read/30771290/identification-expression-analysis-and-functional-characterization-of-motilin-and-its-receptor-in-spotted-sea-bass-lateolabrax-maculatus
#10
Yangyang Zhou, Xin Qi, Haishen Wen, Kaiqiang Zhang, Xiaoyan Zhang, Jin Li, Yun Li, Hongying Fan
Motilin (MLN), an interdigestive hormone secreted by endocrine cells of the intestinal mucosa, binds to a G protein-coupled receptor to exert its biological function of regulating gastrointestinal motility. In the present study, we identified the prepromotilin and mln receptor (mlnr) from the spotted sea bass, Lateolabrax maculatus. Mln consisted of an ORF of 336 nucleotides encoding 111 amino acids. The precursor protein contained a 17-amino-acid mature peptide. Mlnr had an ORF of 1,089 bp encoding a protein of 362 amino acids...
February 13, 2019: General and Comparative Endocrinology
https://read.qxmd.com/read/30771157/mathematical-models-applied-to-thyroid-cancer
#11
REVIEW
Jairo Gomes da Silva, Rafael Martins de Morais, Izabel Cristina Rodrigues da Silva, Paulo Fernando de Arruda Mancera
Thyroid cancer is the most prevalent endocrine neoplasia in the world. The use of mathematical models on the development of tumors has yielded numerous results in this field and modeling with differential equations is present in many papers on cancer. In order to know the use of mathematical models with differential equations or similar in the study of thyroid cancer, studies since 2006 to date was reviewed. Systems with ordinary or partial differential equations were the means most frequently adopted by the authors...
February 15, 2019: Biophysical Reviews
https://read.qxmd.com/read/30770885/genome-wide-identification-characterization-interaction-network-and-expression-profile-of-gras-gene-family-in-sweet-orange-citrus-sinensis
#12
Hua Zhang, Limin Mi, Long Xu, Changxiu Yu, Chen Li, Chunli Chen
GRAS genes are suggested to be grouped into plant-specific transcriptional regulatory families that have been reported to participate in multiple processes, including plant development, phytohormone signaling, the formation of symbiotic relationships, and response to environmental signals. GRAS genes have been characterized in a number of plant species, but little is known about this gene family in Citrus sinensis. In this study, we identified a total of 50 GRAS genes and characterized the gene structures, conserved motifs, genome localizations and cis-elements within their promoter regions...
February 15, 2019: Scientific Reports
https://read.qxmd.com/read/30770300/time-from-definitive-therapy-to-onset-of-metastatic-disease-predicts-outcomes-in-men-with-metastatic-hormone-sensitive-prostate-cancer
#13
Andrew W Hahn, David D Stenehjem, Anitha B Alex, David M Gill, Heather H Cheng, Elizabeth R Kessler, Namita Chittoria, Przemyslaw Twardowski, Ulka Vaishampayan, Neeraj Agarwal
PURPOSE: Contemporary treatment for metastatic hormone sensitive prostate cancer (mHSPC) includes androgen deprivation therapy (ADT) plus abiraterone or docetaxel. While these intensified regimens have improved efficacy, they are also associated with increased cost and toxicities. Not all men with mHSPC may be candidates for these intensified regimens, yet there are no clinical models or biomarkers used to optimize treatment selection. Herein, we hypothesized that longer time from prior definitive therapy (DT), either radical prostatectomy, definitive radiotherapy, or both, to onset of metastatic disease is associated with improved survival outcomes in men with newly diagnosed mHSPC...
February 13, 2019: Urologic Oncology
https://read.qxmd.com/read/30770294/patient-reported-outcomes-following-enzalutamide-or-placebo-in-men-with-non-metastatic-castration-resistant-prostate-cancer-prosper-a-multicentre-randomised-double-blind-phase-3-trial
#14
Bertrand Tombal, Fred Saad, David Penson, Maha Hussain, Cora N Sternberg, Robert Morlock, Krishnan Ramaswamy, Cristina Ivanescu, Gerhardt Attard
BACKGROUND: In the PROSPER trial, enzalutamide significantly improved metastasis-free survival in patients with non-metastatic, castration-resistant prostate cancer. Here, we report the results of patient-reported outcomes of this study. METHODS: In the randomised, double-blind, placebo-controlled, phase 3 PROSPER trial, done at 254 study sites worldwide, patients aged 18 years or older with non-metastatic, castration-resistant prostate cancer and a prostate-specific antigen doubling time of up to 10 months were randomly assigned (2:1) via an interactive voice web recognition system to receive oral enzalutamide (160 mg per day) or placebo...
February 12, 2019: Lancet Oncology
https://read.qxmd.com/read/30770200/the-endometrium-during-and-after-ovarian-hyperstimulation-and-the-role-of-segmentation-of-infertility-treatment
#15
REVIEW
Pedro Montoya-Botero, Nikolaos P Polyzos
Controlled ovarian hyperstimulation (COH) is a crucial part of assisted reproductive technologies (ART) that resulted in a substantial increase in pregnancy rates from in vitro fertilization (IVF). However, in spite of the apparent benefit of COH on an increase in the number of follicles and the number of oocytes retrieved, allowing for extended embryo culture and enabling the selection of the best quality embryo for transfer, several reports has shown that the supraphysiologic hormonal levels may indeed have a detrimental effect at the endometrial level...
September 13, 2018: Best Practice & Research. Clinical Endocrinology & Metabolism
https://read.qxmd.com/read/30769905/clinical-features-survival-and-prognostic-factors-of-glycogen-rich-clear-cell-carcinoma-grcc-of-the-breast-in-the-u-s-population
#16
Zhengqiu Zhou, Connor J Kinslow, Hanina Hibshoosh, Hua Guo, Simon K Cheng, Chunyan He, Matthew S Gentry, Ramon C Sun
The World Health Organization (WHO) defines glycogen-rich clear cell carcinoma (GRCC) of the breast as a carcinoma with glycogen accumulation in more than 90% of its tumor cells. Due to the rarity of this disease, its reported survival and clinical associations have been inconsistent due to reliance on case reports and limited case series. As a result, the prognostic implication of this cancer subtype remains unclear. Using the U.S. Surveillance, Epidemiology, and End Results (SEER) program database, we compared the incidence, demographics and prognostic factors of 155 cases of GRCC of the breast to 1,251,584 cases of other (non-GRCC) breast carcinomas...
February 14, 2019: Journal of Clinical Medicine
https://read.qxmd.com/read/30769013/thermal-manipulation-and-gnrha-therapy-applied-to-the-reproduction-of-lambari-do-rabo-amarelo-astyanax-altiparanae-females-characiformes-characidae-during-the-non-breeding-season
#17
G Brambila-Souza, C C Mylonas, P H Mello, R Y Kuradomi, S R Batlouni, C E Tolussi, R G Moreira
Lambari-do-rabo-amarelo Astyanax altiparanae in the wild reproduce during spring and summer, but females undergo vitellogenesis throughout the year, including the non-spawning winter period when water temperatures are low. The present study investigated the physiological role of temperature modulation on the hypothalamus-pituitary-gonads axis of lambari during winter, as well as the effects of gonadotropin releasing hormone agonist (GnRHa) therapy. Captive females were exposed to two different temperatures (20°C and 27°C) and were injected weekly with GnRHa for 21 days during winter (Control, CTR; Low dose; LD and high dose of GnRHa, HD)...
February 12, 2019: General and Comparative Endocrinology
https://read.qxmd.com/read/30768966/role-of-pcsk9-in-pcos
#18
Meijiao Wang, Dan Zhao, Liangzhi Xu, Wenjing Guo, Li Nie, Yi Lei, Yun Long, Min Liu, Yichen Wang, Xueqin Zhang, Li Zhang, Hanna Li, Jinhu Zhang, Dongzhi Yuan, Limin Yue
BACKGROUND: Proprotein convertase subtilisin / kexin type 9 (PCSK9) plays a critical role in the cholesterol metabolism by negatively regulating the low-density lipoprotein receptor (LDLR). Lipid metabolic and ovarian disorders are the common clinical manifestation of polycystic ovary syndrome (PCOS). Here, we intended to elucidate the role of PCSK9 in the pathogenesis of PCOS conducted on a human population in case-control design and animal part in an interventional study. METHODS: We firstly investigated the serum levels of PCSK9 in 46 PCOS patients compared with 49 healthy women as controls, and then developed a PCOS mouse model induced by dehydroepiandrosterone (DHEA) and a high-fat diet (HFD) to determine the role of PCSK9 in abnormal lipid metabolism and ovarian dysfunction of PCOS in four groups (n = 40 per group): control, PCOS mice, PCOS plus alirocumab group, and PCOS plus vehicle group...
February 12, 2019: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/30767864/the-effect-of-jak1-jak2-inhibition-in-rheumatoid-arthritis-efficacy-and-safety-of-baricitinib
#19
REVIEW
Ernest H S Choy, Corinne Miceli-Richard, Miguel A González-Gay, Luigi Sinigaglia, Douglas E Schlichting, Gabriella Meszaros, Inmaculada de la Torre, Hendrik Schulze-Koops
Numerous cytokines have been implicated in the pathogenesis of inflammatory diseases, and their dysregulation is a main feature of rheumatoid arthritis (RA). Cytokines stimulate signal transduction through several intracellular pathways, including Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathways, leading to changes in cell activation, proliferation and survival. Consequently, agents that selectively target elements of the JAK/STAT pathways have received significant attention in recent years as potential new treatments for the disease...
February 11, 2019: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/30767755/nanocarriers-for-vaginal-drug-delivery
#20
Zeenat Iqbal, Fahima Dilnawaz
BACKGROUND: Vaginal drug delivery approach represents one of the imperative strategies for local and systemic delivery of drugs. The peculiar dense vascular networks, mucus permeability, range of physiological characteristics of the vaginal cavity have been exploited for therapeutic benefit. Furthermore, the vaginal drug delivery has been curtailed due to the influence of different physiological factors like acidic pH, constant cervical secretion, microflora, cyclic changes during periods along with turnover of mucus of varying thickness...
February 15, 2019: Recent Patents on Drug Delivery & Formulation
keyword
keyword
161095
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"